133 related articles for article (PubMed ID: 4696743)
1. Hypocholesterolemic agents and mobilization of tissue cholesterol in man.
Sodhi HS; Kudchodkar BJ; Horlick L
Atherosclerosis; 1973; 17(1):1-19. PubMed ID: 4696743
[No Abstract] [Full Text] [Related]
2. Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.
Sodhi HS; Kudchodkar BJ; Horlick L; Weder CH
Metabolism; 1971 Apr; 20(4):348-59. PubMed ID: 5550302
[No Abstract] [Full Text] [Related]
3. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
Goodman DS; Noble RP; Dell RB
J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
White LW
J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
[No Abstract] [Full Text] [Related]
5. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
Barnhart JW; Sefranka JA; McIntosh DD
Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
[No Abstract] [Full Text] [Related]
6. The application of a simple method to determine the mode of action of oral antihypercholesteremic drugs.
Brandau K; Schlossmann K
Arzneimittelforschung; 1974 Oct; 24(10):1535-42. PubMed ID: 4479759
[No Abstract] [Full Text] [Related]
7. [The treatment of essential hyperlipidemia with clofibrate].
Reuter W; Seifert A
Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
[No Abstract] [Full Text] [Related]
8. A comparison of clofibrate and its derivative methyl clofenapate.
Craig GM
Atherosclerosis; 1972; 15(2):265-71. PubMed ID: 4666129
[No Abstract] [Full Text] [Related]
9. Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
Samuel P; Holtzman CM; Meilman E; Sekowski I
Circulation; 1970 Jan; 41(1):109-14. PubMed ID: 5420622
[No Abstract] [Full Text] [Related]
10. Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia.
Miettinen TA
Atherosclerosis; 1972; 15(2):163-76. PubMed ID: 4666121
[No Abstract] [Full Text] [Related]
11. [Inhibition of cholesterol biosynthesis by mevalonic acid derivatives].
Klimov AN; Klimova TA; Petrova LA; Poliakova ED
Biokhimiia; 1971; 36(4):851-6. PubMed ID: 5095969
[No Abstract] [Full Text] [Related]
12. [Mechanism of action of drugs affecting lipid metabolism].
Rossini L
Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
[No Abstract] [Full Text] [Related]
13. [Treatment of type IV and V hyperlipemia--personal experiences].
Sznajderman M
Pol Arch Med Wewn; 1978 Feb; 59(2):161-9. PubMed ID: 205844
[No Abstract] [Full Text] [Related]
14. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
Craig GM; Walton KW
Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
[No Abstract] [Full Text] [Related]
15. Using designer margarines to control lipid levels.
Cerrato PL
RN; 1999 Oct; 62(10):67-8. PubMed ID: 10578956
[No Abstract] [Full Text] [Related]
16. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
Nordoy A; Rodset JM
Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
[No Abstract] [Full Text] [Related]
17. [Diagnosis and treatment of hyperlipoidaemias].
Wolfram G
Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214
[No Abstract] [Full Text] [Related]
18. The hypocholesterolemic action of eritadenine in the rat.
Takashima K; Izumi K; Iwai H; Takeyama S
Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
[No Abstract] [Full Text] [Related]
19. Separate pools for endogenous and exogenous cholesterol in rat intestines.
Sodhi HS; Orchard RC; Agnish ND; Varughese PV; Kudchodkar BJ
Atherosclerosis; 1973; 17(2):197-210. PubMed ID: 4709120
[No Abstract] [Full Text] [Related]
20. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
Watermeyer GS; Mann JI; Truswell AS; Levy I
S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
